Effects of Fructose Restriction on Liver Steatosis
Sponsored by Maastricht University Medical Center
About this trial
Last updated 5 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Ended 6 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Age ≥ 18 years
- Body mass index ≥ 28 kg/m2
- Fatty liver index ≥ 60
- Fructose intake ≥45 grams/day
Exclusion Criteria
- Medical history of liver disease
- (History of) excessive alcohol consumption (defined as > 2 units/day for women, and > 3 units/day for men)
- Major change in weight and/or physical activity prior to the study
- Use of glucose lowering drugs
- Recent illness
- Pregnancy and/or lactation
- Contraindications for magnetic resonance imaging
- Inability to give informed consent Protocol change (implemented on July 18, 2018): in order to increase the inclusion of study participants, subjects with an average daily fructose intake < 45 gram/day will also be eligible for participation. In subjects who have an average daily fructose intake < 45 gram/day, supplementation of either fructose or glucose (see 'Arms and Interventions') will be increased to 45 gram/day.